Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
LinkedIn adds a pharma 'influencer'
Pfizer CEO Ian Read joins the likes of Bill Gates and Richard Branson in writing for the social network
LinkedIn this week added the first pharma voice to its Influencer articles with a post by Pfizer CEO Ian Read.
The articles have been contributed from business leaders such as Bill Gates and Richard Branson since October 2012 as part of moves towards publishing that have also seen it launch the LinkedIn Today news service.
Read's 'You gain respect in drops, but can lose it in gallons' takes aim at the importance of a pharma company's reputation and just one day after publication had amassed more than 8,500 views.
In terms of engagement the article is doing well too, having so far attracted more than 1,200 shares and 66 comments on LinkedIn, not to mention 45 tweets and 112 Facebook 'likes'.
The Pfizer CEO's debut as an Influencer, one of more than 50 names added, including the CEOs of Nissan and Morgan Stanley, comes as LinkedIn starts opening up its publishing platform to its rank and file members.
Members will be able to share long-form posts to their LinkedIn profile and, in a Facebook-like move, they can be followed by LinkedIn members with which they are not connected.
Featured jobs
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
Subscribe to our email news alerts
- Boehringer taps Korea’s Bridge for Ofev follow-up
- Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
- Novartis and J&J back latest €400m Medicxi biopharma fund
- How To Get To A Great Culture by Dave Birss
- Episode 2: Alder Play - Cameron Day (ustwo)
- Episode 1: Patient Centricity on Trial - Claire Knapp and Mark Evans, Havas Lynx Group, Keynote
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
